Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibikase Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 90K | Apr 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 2, 2024 | Chief Financial Officer |
IKT | Inhibikase Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 2, 2024 | Chief Financial Officer |